Docarpamine
A dopamine prodrug used in the treatment of heart failure and other conditions
Docarpamine is a prodrug of dopamine, primarily used in the treatment of heart failure and other conditions where increased dopaminergic activity is desired. It is designed to enhance the bioavailability of dopamine when administered orally, overcoming the limitations of direct dopamine administration.
Pharmacology[edit | edit source]
Docarpamine is metabolized in the body to release dopamine, which then exerts its effects by stimulating dopamine receptors. Dopamine is a key neurotransmitter in the central nervous system and plays a significant role in regulating cardiovascular and renal functions. By acting on dopamine receptors, docarpamine can improve cardiac output and renal perfusion, making it beneficial in conditions like heart failure.
Mechanism of Action[edit | edit source]
As a prodrug, docarpamine itself is not active. Once ingested, it undergoes enzymatic conversion in the body to release dopamine. The released dopamine then binds to dopamine receptors, particularly the D1 and D2 subtypes, leading to vasodilation and increased renal blood flow. This action helps in reducing the workload on the heart and improving symptoms of heart failure.
Clinical Uses[edit | edit source]
Docarpamine is used in the management of heart failure, particularly in patients who require enhanced dopaminergic activity to improve cardiac function. It may also be used in other conditions where increased dopamine activity is beneficial, such as certain types of shock or renal failure.
Side Effects[edit | edit source]
The side effects of docarpamine are primarily related to its dopaminergic activity. Common side effects include nausea, vomiting, headache, and tachycardia. In some cases, patients may experience hypotension or arrhythmias.
Administration[edit | edit source]
Docarpamine is administered orally, which is an advantage over direct dopamine administration that typically requires intravenous delivery. This makes it more convenient for outpatient management of chronic conditions.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
